This bill mandates that various health insurance providers in New Jersey, including hospital service corporations, medical service corporations, health service corporations, individual and group health insurance policies, health maintenance organizations, and health benefits plans, must cover expenses related to the purchase and use of continuous glucose monitoring systems. This coverage is specifically for the treatment of glycogen storage disease and must be provided to the same extent as coverage for any other medical condition under the respective contracts or policies.

The bill applies to contracts and policies that are delivered, issued, executed, or renewed on or after the effective date of the act, which is set for the first day of the seventh month following its enactment. Additionally, it ensures that the State Health Benefits Commission and the School Employees Health Benefits Commission will also provide this coverage in their respective contracts. Overall, the legislation aims to enhance access to necessary medical technology for individuals suffering from glycogen storage disease.